American biopharmaceutical company based in Boston, Massachusetts, one of the first biotech firms to use an explicit strategy of rational drug design; develops medications for cystic fibrosis, genetic disorders, and pain management.
Clinical Trials
663
405 active
Approvals
11
Total approvals
Agencies
1
Regulatory bodies
Founded
1989
Active, not recruiting
398
60.0%
Approved For Marketing
4
0.6%
Completed
191
28.8%
Enrolling By Invitation
3
0.5%
Not yet recruiting
4
0.6%
Recruiting
43
6.5%
Terminated
18
2.7%
Withdrawn
2
0.3%
No news articles found
